Brook Itzhak
Department of Pediatrics, Georgetown University School of Medicine, 4431 Albemarle Street NW, Washington, DC 20016, USA.
J Gastroenterol Hepatol. 2005 Feb;20(2):182-6. doi: 10.1111/j.1440-1746.2004.03466.x.
This review presents the microbiology, management and prevention of pseudomembranous colitis (PMC) in children. PMC is commonly associated with prior antibiotic exposure and hospitalization. It is caused almost exclusively by toxins produced by Clostridium difficile. The clinical spectrum of this disease may range from a mild, non-specific diarrhea to severe colitis with toxic megacolon, perforation, and death. PMC may affect all age groups, although a lower incidence has been noted in children. Ampicillin, amoxicillin, the second- and third-generation cephalosporins and clindamycin are the drugs most frequently associated with development of PMC, although nearly all antimicrobials have been implicated as causes of diarrhea and colitis. Discontinuation of antibiotics and supportive therapy usually lead to resolution of this disorder. Administration of oral vancomycin or other therapeutic regimens may be needed.
本综述介绍了儿童伪膜性结肠炎(PMC)的微生物学、管理和预防。PMC通常与先前使用抗生素和住院有关。它几乎完全由艰难梭菌产生的毒素引起。这种疾病的临床谱可能从轻度、非特异性腹泻到伴有中毒性巨结肠、穿孔和死亡的严重结肠炎。PMC可能影响所有年龄组,尽管儿童中的发病率较低。氨苄西林、阿莫西林、第二代和第三代头孢菌素以及克林霉素是与PMC发生最常相关的药物,尽管几乎所有抗菌药物都被认为是腹泻和结肠炎的病因。停用抗生素和支持性治疗通常会导致这种疾病得到缓解。可能需要给予口服万古霉素或其他治疗方案。